Nina Friis-Møller
Friis-Møller, Nina
VIAF ID: 307233925 (Personal)
Permalink: http://viaf.org/viaf/307233925
Preferred Forms
-
- 100 0 _ ‡a Nina Friis-Møller
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies | |
Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort | |
[Carbon monoxide poisoning] | |
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study. | |
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology | |
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study | |
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome | |
Highly active antiretroviral therapy and coronary heart disease: the need for perspective. | |
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies | |
Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV | |
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis | |
Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir. | |
Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate | |
Incidence of abacavir hypersensitivity reactions in euroSIDA. | |
Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. | |
Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial | |
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? | |
Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function | |
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | |
Predictors of hypertension and changes of blood pressure in HIV-infected patients. | |
The prevalence and clinical significance of intestinal parasites in HIV-infected patients in Denmark | |
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen | |
Risk of cardiovascular disease in HIV-infected persons | |
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study | |
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration |